Yohann Rautureau
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection.
Journal: Cardiovascular research
Published: August 18, 2021
ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
Journal: Circulation
Published: April 21, 2018
HDL biogenesis revisited: how desmocollin-1 could sabotage reverse cholesterol transport in the arterial wall.
Journal: European heart journal
Published: October 12, 2017
Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 25, 2017
Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: December 29, 2015
Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 09, 2015
Preservation of endothelium-dependent relaxation in atherosclerotic mice with endothelium-restricted endothelin-1 overexpression.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 02, 2013
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Journal: Cardiovascular research
Published: December 20, 2012
Endothelin in hypertension: an update.
Journal: Current opinion in nephrology and hypertension
Published: January 20, 2012
Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: December 21, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026